Bayforest Capital »

BioCryst Pharmaceuticals shares owned by Bayforest Capital

Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Bayforest Capital from 13F filings

Historical chart of Bayforest Capital investment in BioCryst Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including BioCryst Pharmaceuticals held by Bayforest Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in BioCryst Pharmaceuticals by Bayforest Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $532k 70k 7.59
2025-06-30 $840k 94k 8.96

More positions owned by Bayforest Capital

Solaredge Technologies (SEDG)
Peloton Interactive Cl A Com (PTON)
Crown Castle Intl (CCI)
Mercury Computer Systems (MRCY)
Cirrus Logic (CRUS)
Dollar Tree (DLTR)
Humana (HUM)
Trinet (TNET)
InterDigital (IDCC)
CVR Energy (CVI)
Celsius Hldgs Com New (CELH)
Frontdoor (FTDR)
Irhythm Technologies (IRTC)
Jack Henry & Associates (JKHY)
Kilroy Realty Corporation (KRC)

View all positions for Bayforest Capital

Top funds holding BioCryst Pharmaceuticals

Vanguard Group
BlackRock
Deerfield Management Company
State Street Corporation
Kynam Capital Management
UBS Group
Alkeon Capital Management
Morgan Stanley
Arrowstreet Capital, Limited Partnership
Geode Capital Management
Two Sigma Investments
Two Sigma Advisers
Hood River Capital Management
Nuveen
Assenagon Asset Management

View all funds holding BioCryst Pharmaceuticals